Central sleep apnea (CSA) is a common, though often unrecognized, finding in congestive
heart failure (HF) patients that is associated with poor quality of life and increased morbidity …

Central sleep apnoea (CSA) occurs in a large proportion of HF patients. CSA has clear
detrimental effects, resulting in intermittent hypoxia and sympathetic activation, and is …

There is increasing awareness of sleep-disordered breathing, which may manifest as
obstructive sleep apnea, central sleep apnea (CSA), or a mixture of the two. Obstructive …

Congestive heart failure (CHF) is a major clinical and public health problem (1). For
example, in the United States, the prevalence of CHF among those aged 50–59 years is 1 …

Respiratory sleep disorders (RSD) occur in about 40-50% of patients with symptomatic
congestive heart failure (CHF). Obstructive sleep apnea (OSA) is considered a cause of …

Sleep plays a large role in patients with heart failure. In normal subjects, sleep is usually in a
supine position with reduced sympathetic drive, elevated vagal tone and as such a relatively …

Central sleep apnea (CSA) affects many patients, with heart failure and results in hypoxia
and nor-epinephrine release and is associated with high morbidity and mortality. Recent …

Central sleep apnea is a devastating disease which occurs in approximately 40% of patients
with heart failure as well as patients with a history of stroke, opioid use and neurological …

It is known that patients with heart failure (HF) have an increased risk of developing central
sleep apnoea (CSA), with Cheyne-Stokes respiration. The development of servo-ventilation …

As an adjunct to optimal pharmacological management, adaptive servo-ventilation shows
considerable promise as a means to improve outcomes in patients with congestive heart …